Colin McGuckin

CTI-LYON, Cell Therapy Research Institute, Parc Technologique de Lyon, France

Colin McGuckin completed a postdoctoral position at the Department of Haematology, St George’s Hospital Medical School working on chronic anaemia’s and stem cell disorders after finishing his Ph.D. (D.Phil.) degree on leukaemia research in 1991. In 1996, he became a Senior Lecturer in biomedical sciences at the Kingston University, and Reader in 2001. In 1999, he founded and became the Director of the Stem Cell Therapy Laboratory specializing in stem cell research and regenerative medicine. In 2005, he was appointed the First Professor of regenerative medicine at Newcastle University, UK, leading clinical research in adult stem cells through to patients. In 2008, he cofounded the Novus Sanguis Charitable Consortium for Responsible Regenerative Medicine, providing grant funding internationally in adult stem cells. In January 2009, he became the President of the Cell Therapy Research Institute, Lyon, France, an Adult Stem Cell Centre. Professor McGuckin’s group was first in the world to characterise and produce embryonic-like stem cells from umbilical cord blood [McGuckin et al., Cell Proliferation, 38, 245-255, 2005]. They are also first to make nervous, pancreatic, hepatic, bile epithelium and a range of other tissues from umbilical cord, cord blood, and adipose related stem cells. Professor McGuckin is on the editorial boards of 4 international journals, international reviewer (Eg. European Commission), and an advisor to several medical and science organizations. He has been invited to speak internationally, including the European Parliament, The Bundestag German Parliament, The Austrian Parliament, the French Senate, the Vatican, Rome, and the USA government at the US Senate on Capitol Hill. He is also the President of Novus Sanguis.

Biography Updated on 22 December 2011

Scholarly Contributions [Data Provided by scopus]